Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Joshua T. Rose, Eliana Moskovitz, Joseph R. Boyd, Jonathan A. Gordon, Nicole A. Bouffard, Andrew J. Fritz, Anuradha Illendula, John H. Bushweller, Jane B. Lian, Janet L. Stein, Sayyed K. Zaidi, Gary S. Stein
Published May 30, 2020 · Vol. 11, No. 26 · pp. 2512-2530
Alessandra Pulliero, Ming You, Pradeep Chaluvally-Raghavan, Barbara Marengo, Cinzia Domenicotti, Barbara Banelli, Paolo Degan, Luigi Molfetta, Fabio Gianiorio, Alberto Izzotti
Published May 10, 2020 · Vol. 11, No. 22 · pp. 2106-2119
Keywords: circulating microRNAs, sports and exercise, carcinogenesis, cancer prevention, microRNA transfection
Mai Ahmed Shafei, Thomas Forshaw, Jasmine Davis, Arwa Flemban, David Qualtrough, Sarah Dean, Claire Perks, Ming Dong, Robert Newman, Myra Elizabeth Conway
Published May 8, 2020 · Vol. 11, No. 21 · pp. 1971-1987
Salvatore Del Prete, Liliana Montella, Grazia Arpino, Giuseppe Buono, Carlo Buonerba, Pasquale Dolce, Olga Fiorentino, Maria Aliberti, Antonio Febbraro, Clementina Savastano, Giuseppe Colantuoni, Ferdinando Riccardi, Angela Ruggiero, Sabino De Placido, Michele Orditura
Published May 6, 2020 · Vol. 11, No. 22 · pp. 2083-2091
Keywords: breast cancer, metastatic, Her-2 positive, trastuzumab emtansine, pertuzumab
Diana Barea Roldán, Matthias Grimmler, Christoph Hartmann, Stefanie Hubich-Rau, Tim Beißert, Claudia Paret, Giuseppe Cagna, Christoph Rohde, Stefan Wöll, Michael Koslowski, Özlem Türeci, Ugur Sahin
Published Apr 22, 2020 · Vol. 11, No. 20 · pp. 1862-1875
Inês Gomes, Bernardo P. de Almeida, Sara Dâmaso, André Mansinho, Inês Correia, Sara Henriques, Raquel Cruz-Duarte, Guilherme Vilhais, Pedro Félix, Patrícia Alves, Patrícia Corredeira, Nuno L. Barbosa-Morais, Luis Costa, Sandra Casimiro
Published Apr 18, 2020 · Vol. 11, No. 19 · pp. 1714-1728
Keywords: RANKL-RANK pathway, ER+ breast cancer, resistance to chemo and hormone therapy, stemness, metastization
Camila Maria Simplicio-Revoredo, Renato de Oliveira Pereira, Mariella de Almeida Melo, Pedro Vitor Lopes-Costa, Paulo de Tarso Moura-Borges, Emerson Brandão Sousa, Fidelis Manes Neto, Viriato Campelo, Ione Maria Ribeiro Soares-Lopes, Maria da Conceição Barros-Oliveira, Cleciton Braga Tavares, Alesse Ribeiro dos Santos, Camila Guedes Borges de Araújo, Eid Gonçalves Coelho, Larysse Cardoso Campos-Verdes, Aldenora Oliveira do Nascimento-Holanda, Jackeline Lopes Viana, Maria Liduina Meneses Bezerra-Chaves, Rodrigo José de Vasconcelos-Valença, Lina Gomes dos Santos, Lauro Rodolpho Soares-Lopes, André Luiz Pinho-Sobral, Luiz Henrique Gebrim, Benedito Borges da Silva
Published Apr 18, 2020 · Vol. 11, No. 18 · pp. 1629-1636
Keywords: breast cancer, fibroadenoma, NRF2, NF-κB, immunohistochemistry
David J. Lamb, Aleksander Rust, Albin Rudisch, Tobias Glüxam, Nathalie Harrer, Herwig Machat, Ingrid Christ, Florian Colbatzky, Andreas Wernitznig, Annika Osswald, Wolfgang Sommergruber
Published Apr 7, 2020 · Vol. 11, No. 14 · pp. 1257-1272
Keywords: SYK inhibitor, breast carcinoma, 3D culture, murine mammary gland, proliferation